Platelets and eltrombopag: A not-so-sticky situation

Blood

Volumn 119, Issue 17, 2012, Pages 3876-3877

  Lambert, Michele P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELTROMBOPAG; ROMIPLOSTIM;

AUTOIMMUNE THROMBOCYTOPENIA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; MEGAKARYOCYTE; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 84860322900     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-410415     Document Type: Note

References (11)

1. Psaila B, Bussel JB, Linden MD, et al. In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood. 2012; 119(17):4066-4072.
2. Harker LA, Marzec UM, Hunt P, et al. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood. 1996;88(5):511-521. (Pubitemid 26240383)
3. Cuker A. Toxicities of the thrombopoietic growth factors. Semin Hematol. 2010;47(3):289-298.
4. Erhardt JA, Erickson-Miller CL, Aivado M, Abboud M, Pillarisetti K, Toomey JR. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function. Exp Hematol. 2009;37(9):1030-1037.
5. Jy W, Horstman LL, Park H, Mao WW, Valant P, Ahn YS. Platelet aggregates as markers of platelet activation: characterization of flow cytometric method suitable for clinical applications. Am J Hematol. 1998;57(1):33-42. (Pubitemid 28047196)
6. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood. 1996;87(12):4925-4936. (Pubitemid 26189833)
7. McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells. 1990;16(1):73-80, discussion 80-83.
8. Severinsen MT, Engebjerg MC, Farkas DK, et al. Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol. 2011;152(3):360-362.
9. Cuker A, Cines DB. Immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2010;2010:377-384. Review.
10. Panzer S, Hocker L, Vormittag R, et al. Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia. Pediatr Blood Cancer. 2006;47(5 suppl):694-696. (Pubitemid 44360032)
11. Haselboeck J, Pabinger I, Ay C, Koder S, Panzer S. Platelet activation and function during eltrombopag treat-mentinimmune thrombocytopenia. Ann Hematol. 2012;91(1):109-113.